XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
EXICURE, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.03−0.09 (-8.04%)
Close on Oct 19, 2026
- Market cap
- $6.57M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$3.51 (−77.31%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
EXICURE, INC. reported revenue of $0 for the twelve months to Jun 30, 2026. Free cash flow was -$8.56M.
Revenue
$0
TTM Q2 2026
Operating income
-$7.34M
TTM Q2 2026
Free cash flow
-$8.56M
FY2025
EPS, diluted
-$1.31
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $6.57M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 6.72
- Dividend yield
- –
- Free cash flow yield
- -130.32%
Fundamentals
- Revenue
- $0
- Net income
- -$8.28M
- EPS, diluted
- -$1.31
- Free cash flow
- -$8.56M
- Book value per share
- $0.15
- Diluted shares
- 6M
Eleven years at a glance
Fiscal years 2015 to 2025 and trailing twelve months, USD
Revenue
$0
Operating income
-$7.34M
Net income
-$8.28M
EPS, diluted
-$1.31
Free cash flow
–
Reported periodTrailing twelve months